Evidence map›Paper›PMID 35508915›Full record

ArticleEuropean journal of heart failure2022

Characteristics, management, and outcomes of patients with left-sided infective endocarditis complicated by heart failure: a substudy of the ESC-EORP EURO-ENDO (European infective endocarditis) registry.

Yohann Bohbot, Gilbert Habib, Cécile Laroche, Elisabeth Stöhr, Catherine Chirouze, Marta Hernandez-Meneses, Maria Melissopoulou, Bülent Mutlu, Valentina Scheggi, Luísa Branco and 9 more

Open access · bronzeAbstract readComment
In one paragraph

Article in European journal of heart failure, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 2 institutions in 11 countries.

Yohann BohbotDepartment of Cardiology, Amiens University Hospital, Amiens, France.ORCID 0000-0002-2695-9848
Gilbert HabibDepartment of Cardiology, Hôpital de la Timone, Aix-Marseille University, Marseille University Hospital, Marseille, France.ORCID 0000-0003-3899-9983
Cécile LarocheEURObservational Research Programme, European Society of Cardiology, Heart House, Sophia Antipolis, France.
Elisabeth StöhrDepartment of Cardiology, Heart Center, University of Bonn, Bonn, Germany.
Catherine ChirouzeMaladies Infectieuses et Tropicales - Centre Hospitalier Régional Universitaire, Besançon, France; UMR-CNRS 6249 Chrono-Environnement, Université Bourgogne Franche-Comté, Besançon, France.
Marta Hernandez-MenesesDepartment of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
Maria MelissopoulouDepartment of Cardiology, CHR Citadelle, Liège, Belgium.
Bülent MutluDepartment of Cardiology, Marmara University Istanbul Pendik Educational and Research Hospital, Istanbul, Turkey.
Valentina ScheggiDivision of Cardiovascular and Perioperative Medicine, Cardiothoracovascular Department, Azienda Ospedaliero-Universitaria Careggi and University of Florence, Florence, Italy.
Luísa BrancoDepartment of Cardiology, Santa Marta Hospital, Lisbon, Portugal.
Carmen OlmosInstituto Cardiovascular, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdSSC), Madrid, Spain.
Graciela ReyesEcho Lab Department, Hospital de Alta Complejidad en red El Cruce, Florencio Varela, Buenos Aires, Argentina.
Michal PazdernikDepartment of Cardiology, IKEM, Prague, Czech Republic; Department of Cardiology, 2nd Medical School, Charles University, University Hospital Motol, Prague, Czech Republic.
Bernard IungUniversité de Paris and Institut National de la Santé et de la Recherche Scientifique 1148, Paris, France.ORCID 0000-0002-9127-348X
Rouguiatou SowDepartment of cardiology, Luxembourg Hospital Centre, Luxembourg, Luxembourg.
Maja MirocevicDepartment of Cardiology, Clinical Centre of Montenegro, Podgorica, Montenegro.
Patrizio LancellottiCardiology Department, University Hospital Centre, Centre Hospitalier Universitaire (CHU) Sart Tilman, Liège, Belgium.ORCID 0000-0002-0804-8194
Christophe TribouilloyDepartment of Cardiology, Amiens University Hospital, Amiens, France.
EORP EURO-ENDO Registry Investigators Group
European Organisation for Rare Diseases · FREuropean Society of Cardiology · FR

Funding

British Heart Foundation CH/1996001/9454Medical Research Council MC_UU_00017/3
6 · The paper itself

Abstract

aimsTo evaluate the current management and survival of patients with left-sided infective endocarditis (IE) complicated by congestive heart failure (CHF) in the ESC-EORP European Endocarditis (EURO-ENDO) registry. METHODS AND

resultsAmong the 3116 patients enrolled in this prospective registry, 2449 (mean age: 60 years, 69% male) with left-sided (native or prosthetic) IE were included in this study. Patients with CHF (n = 698, 28.5%) were older, with more comorbidity and more severe valvular damage (mitro-aortic involvement, vegetations >10 mm and severe regurgitation/new prosthesis dehiscence) than those without CHF (all p ≤ 0.019). Patients with CHF experienced higher 30-day and 1-year mortality than those without (20.5% vs. 9.0% and 36.1% vs. 19.3%, respectively) and CHF remained strongly associated with 30-day (odds ratio[OR] 2.37, 95% confidence interval [CI] [1.73-3.24; p < 0.001) and 1-year mortality (hazard ratio [HR] 1.69, 95% CI 1.39-2.05; p < 0.001) after adjustment for established outcome predictors, including early surgery, or after propensity matching for age, sex, and comorbidity (n = 618 [88.5%] for each group, both p < 0.001). Early surgery, performed on 49% of these patients with IE complicated by CHF, remained associated with a substantial reduction in 30-day mortality following multivariable analysis, after adjustment for age, sex, Charlson comorbidity index, cerebrovascular accident, Staphylococcus aureus IE, streptococcal IE, uncontrolled infection, vegetation size >10 mm, severe valvular regurgitation and/or new prosthetic dehiscence, perivalvular complication, and prosthetic IE (OR 0.22, 95% CI 0.12-0.38; p < 0.001) and in 1-year mortality (HR 0.29, 95% CI 0.20-0.41; p < 0.001).

conclusionCongestive heart failure is common in left-sided IE and is associated with older age, greater comorbidity, more advanced lesions, and markedly higher 30-day and 1-year mortality. Early surgery is strongly associated with lower mortality but is performed on only approximately half of patients with CHF, mainly because of a surgical risk considered prohibitive.

Indexed as

EndocarditisEndocarditis, BacterialHeart FailureFemaleHospital MortalityHumansMaleMiddle AgedProspective StudiesRegistriesRetrospective StudiesCongestive heart failureEarly surgeryEURO-ENDOInfective endocarditisOutcomeSurvival

Identifiers

PMID35508915
PMCPMC9543970
OpenAlexW4228999053

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.